New hope for stubborn eye disease when other drugs fail
NCT ID NCT05651880
Summary
This study is testing whether the drug baricitinib can control a specific type of serious, persistent eye inflammation called uveitis in patients for whom other powerful biologic treatments have not worked. It will involve 33 adults who have this condition and need to stop their current medications to try this new approach. The main goal is to see how many patients achieve complete remission of their eye inflammation after six months of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE NON-ANTERIOR NON-INFECTIOUS UVEITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.